title: [Serious lung disease in RA and TNF-blockade--is there a connection?].
authors.forename: Carl
authors.initials: C
authors.lastname: Turesson
authors.forename: Lennart
authors.initials: L
authors.lastname: Jacobsson
authors.forename: Tore
authors.initials: T
authors.lastname: Saxne
authors.forename: Pierre
authors.initials: P
authors.lastname: Geborek
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D011658:Pulmonary Fibrosis / Q000139:chemically induced*; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab